jo_k_er_man
06-03-2005, 05:16 AM
Fukuoka, Japan: Administration of the non-psychoactive cannabinoid
cannabidiol (CBD) is neuroprotective against cerebral infarction
(localized cell death in the brain) in mice, according to clinical trial
data published in the May issue of the journal Stroke.
"Treatment of cannabidiol ... significantly reduced the infarct volume
... in mice" in a dose dependent manner, a research team at Fukuoka
University's Department of Neuropharmacology concluded. Authors
speculated that CBD "exerts a neuroprotective effect through its
anti-oxidant, anti-spasmodic, and anti-emetic activity, [as well as
through] vasorelaxation."
Researchers at the National Institutes of Mental Health (NIMH) have
previously reported that cannabinoids are neuroprotective in animals
against brain damage caused by alcohol and/or stroke.
For more information, please contact Paul Armentano, NORML Senior
Policy Analyst, at (202) 483-5500. Full text of the study, "Cannabidiol
prevents cerebral infarction," is available in the May issue of the
journal Stroke.
cannabidiol (CBD) is neuroprotective against cerebral infarction
(localized cell death in the brain) in mice, according to clinical trial
data published in the May issue of the journal Stroke.
"Treatment of cannabidiol ... significantly reduced the infarct volume
... in mice" in a dose dependent manner, a research team at Fukuoka
University's Department of Neuropharmacology concluded. Authors
speculated that CBD "exerts a neuroprotective effect through its
anti-oxidant, anti-spasmodic, and anti-emetic activity, [as well as
through] vasorelaxation."
Researchers at the National Institutes of Mental Health (NIMH) have
previously reported that cannabinoids are neuroprotective in animals
against brain damage caused by alcohol and/or stroke.
For more information, please contact Paul Armentano, NORML Senior
Policy Analyst, at (202) 483-5500. Full text of the study, "Cannabidiol
prevents cerebral infarction," is available in the May issue of the
journal Stroke.